1.Rispoli DZ, Camargo PM, Pires JL Jr, Fonseca VR, Mandelli KK, Pereira MA. Benign masseter muscle hypertrophy. Braz J Otorhinolaryngol 2008;74:790-3.

2.Al-Ahmad HT, Al-Qudah MA. The treatment of masseter hypertrophy with botulinum toxin type A. Saudi Med J 2006;27:397-400.

3.Waldhart E, Lynch JB. Benign hypertrophy of the masseter muscles and mandibular angles. Arch Surg 1971;102:115-8.

4.Yu CC, Chen PK, Chen YR. Botulinum toxin A for lower facial contouring: A prospective study. Aesthetic Plast Surg 2007;31:445-51.

5.Parente E, Silvares M, Naegele M, Ribeiro D, Andrade M. Surgical treatment of bilateral temporalis and masseteric hypertrophy: Report of a case. Open J Stomatol 2013;3:99-102.

6.Jin Park Y, Woo Jo Y, Bang SI, Kim HJ, Lim SY, Mun GH, et al. Radiofrequency volumetric reduction for masseteric hypertrophy. Aesthetic Plast Surg 2007;31:42-52.

7.Teixeira VC , Mejia JE , Estefano A. Surgical treatment of benign masseter by intraoral approach. Rev Bras Surgery 1996;86: 165-70.

8.Smyth AG. Botulinum toxin treatment of bilateral masseteric hypertrophy. Br J Oral Maxillofac Surg 1994;32:29-33.

9.Özkan BT, Tabrizi R, Cigerim L. Management of bilateral masseter muscle hypertrophy. J Craniofac Surg 2012;23:e14-6.

10.Andrade NN, Deshpande GS. Use of botulinum toxin (botox) in the management of masseter muscle hypertrophy: A simplified technique. Plast Reconstr Surg 2011;128:24e-6e

11.Moore AP, Wood GD. The medical management of masseteric hypertrophy with botulinum toxin type A. Br J Oral Maxillofac Surg 1994;32:26-8

12.Sannomya EK, Gonçalves M, Cavalcanti MP. Masseter muscle hypertrophy: Case report. Braz Dent J 2006;17:347-50.

13.Klein FH, Brenner FM, Sato MS, Robert FM, Helmer KA. Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy. An Bras Dermatol. 2014;89:878-84

14.Andreadis D, Stylianou F, Tsatsouli L, Markopoulos A. Bilateral masseter and internal pterygoid muscle hypertrophy: A diagnostic challenge. Med Princ Pract 2014;23:286-8.

15.Huang JL, Chen G, Chen XD, Zhou BR, Luo D. A comparative study of the efficacy and safety of radiofrequency ablation and botulinum toxin A in treating masseteric hypertrophy. Exp Ther Med 2014;7:1203-1208.

16.Kebede B, Megersa S. Idiopathic masseter muscle hypertrophy. Ethiop J Health Sci 2011;21:209-12.

17.Kim JH, Shin JH, Kim ST, Kim CY. Effects of two different units of botulinum toxin type a evaluated by computed tomography and electromyographic measurements of human masseter muscle. Plast Reconstr Surg 2007;119:711-7.